BAM
KIN

Blueshift Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Blueshift Asset Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,941
Closed -$183K – 1389
2021
Q2 		$183K Buy
+19,941
New +$116K 0.01% 849

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Blueshift Asset Management's KIN Position: Q3 2021 in Review

Blueshift Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 19,941 shares — an estimated $183K sold.

Blueshift Asset Management first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $183K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Blueshift Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 19,941 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $183K.
  • Blueshift Asset Management first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Blueshift Asset Management's Kindred Biosciences, Inc. position peaked at $183K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Blueshift Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.